cabozantinib,atezolizumab
exelixis,roche
['lcsm,(-blcsm)', 'cosmic 021']
#lcsm #asco22 cosmic 021 study by dr. joel neal post io patients 
Assistant Professor, Thoracic Oncologist, University of Minnesota | Masonic Cancer Center